Context: Cryptorchidism is common in Prader-Willi syndrome (PWS) males, but the testicular histology in childhood remains uncertain. The association between testicular histology and long-term gonadal function in PWS males is also unknown.
| INTRODUC TI ON
Prader-Willi syndrome (PWS) is a genetic disorder resulting from the lack of expression of the paternally derived chromosome 15q11-q13. 1, 2 It is caused by a deletion (70%), uniparental disomy (25%), imprinting centre defect (5%), or balanced translocation. 1, 2 PWS is characterized by hypotonia, hyperphagia, obesity, short stature, behaviour disorder and hypogonadism. Clinical signs of hypogonadism in PWS males include cryptorchidism, scrotal hypoplasia, small testicular volume, delayed or incomplete pubertal development and infertility. Because most symptoms of PWS are considered to result from hypothalamic dysfunction, hypogonadism in PWS was hypothesized to be hypogonadotropic. [3] [4] [5] However, recent studies of hypothalamic, pituitary and testicular function in PWS have shown that all forms of hypogonadism (central origin, peripheral and combined) are found in males with PWS. [6] [7] [8] [9] Cryptorchidism is found in a majority of PWS males, but only two reports have evaluated the testicular histology of PWS males. 10, 11 These studies demonstrated that testicular histology ranged from normal seminiferous tubule tissue with germ cells to Sertoli Cell-Only Syndrome (SCOS), but the details remain uncertain because they were small case series. 10, 11 Further, the association between testicular histology in childhood and the long-term prognosis for gonadal function in PWS males remain unclear, because no data are available.
The aim of this study was to evaluate the testicular histology of PWS males in childhood and determine the association between testicular histology in childhood and long-term gonadal function.
| MATERIAL S AND ME THODS

| Patients
After receiving Institutional Review Board approval, the charts of 40 male children and adults (mean 12.1 ± 8.3 years; range 1.0-28.0 years) consecutively diagnosed with PWS at our institute from July 1991 to August 2015 were retrospectively reviewed. The mean follow-up was 10.6 ± 7.8 years (range, 0.6-25.0 years). Thirtyseven patients (92.5%) were longitudinally assessed until the present study, but three patients were followed by another hospital.
Children were followed every 3 months by clinical examinations and at least once a year by blood sampling. After 18 years, they were followed every 6 months. Pubertal development was evaluated using the Tanner classification 12 by a paediatric endocrinologist (SI).
Puberty was defined as Tanner pubertal stage 2 (G2).
| Hormone assays
Blood samples were periodically taken to measure LH, FSH and testosterone levels. Serum FSH and LH levels were determined using a two-site enzyme immune-assay (TOSOH I; TOSOH, Tokyo, Japan).
From March 2000, serum FSH and LH levels were determined using TOSOH II. Total serum testosterone was determined by chemiluminescent immunoassay (TOSOH I, TOSOH), up to June 2013. Since
July 2013, total serum testosterone was determined by enzyme The values in the group at 2 y before puberty onset differed significantly from the values in the group at puberty onset for LH, P < 0.009; FSH, P < 0.001; and T, P < 0.0001. The values in the group at 1 y before puberty onset differed significantly from the values in the group at puberty onset for LH, P < 0.005; FSH, P < 0.001; and T, P < 0.0001. The values in the group at adults differed significantly from the values in the group at puberty onset for LH, P < 0.005; FSH, P < 0.001; and T, P < 0.0007 immunoassay (TOSOH II, TOSOH). Values for LH and FSH obtained in the newer TOSOH II assay comparable to those measured in the older TOSOH I assay. 13, 14 Values for testosterone were comparable in the older and newer assays. 15 Detectable levels were 0.2-200 mIU/mL for LH, 0.1-200 mIU/mL for FSH and 7-2000 ng/ dL for testosterone. For ethical reasons, no age-matched control group consisting of healthy children and men was available. The hormonal data were compared with previously published age-dependent reference values in Japan. 16, 17 As shown in Figure 1 , we divided the hormonal data into puberty related six groups: 2 years before puberty onset, 1 year before puberty onset, puberty onset, 1 year after puberty onset, 2 years after puberty onset, and adults (>18 years). with PWS, and all of them underwent orchiopexy at 1.9 ± 1.1 years (0.8-6.3 years) at our institute. Forty-four testes (71%) were extra-canalicular testes, 10 (16.1%) were intra-abdominal testes, and 8 (12.9%)
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were intra-canalicular testes. The remaining five males presented bilaterally descended testis. The mean long diameter of the testes was 11.0 ± 1.9 mm (6.0-15.0 mm) ( Table 1 ). The mean follow-up after orchiopexy was 10.7 ± 7.7 years (0.2-23.5 years). Among patients who did not undergo orchiopexy, the mean follow-up was 9.3 ± 8.3 years (0.9-23.1 years). Twenty-nine patients were on GH treatment.
| Pubertal development
Of 14 patients older than 15 years during this study (Table 2) onset of puberty was at a mean age of 11 ± 1.1 years (10.0-13.0 years).
The remaining patient (Case 14 in On the other hand, three patients had a prior history of early pubertal development. Patient 1 was 8.0 years boy. Height was 122.1 cm (−1 SD), pubic hair (Ph) 2 and testis 3 mL. We found increased growth velocity (7 cm/y), and advanced bone age (9.9 years).
Serum levels of LH were normal (LH 2.2 mIU/mL), but FSH and testosterone levels were high (FSH 18.2 mIU/mL and testosterone 216.5 ng/dL, respectively), Pituitary MRI was normal. At 9.7 years, the patient presented bone age of 12.3 years. Patient 2 was 8.0 years boy, height was 119.5 cm (−1 SD), and Ph 2. We found increased growth velocity (9 cm/y), and advanced bone age (7.9 years) at 7.0 years. Serum levels of LH and FSH were normal (LH 0.2 mIU/mL and FSH 1.0 mIU/mL, respectively), but testosterone levels were high (testosterone 37.3 ng/dL). Pituitary MRI was normal. At 9.9 years, the patient presented bone age of 11.6 years.
Patient 3 was 9.0 years boy, height was 132.9 cm (+1 SD), Ph 2 and testis 5 mL. We found increased growth velocity (7 cm/y), high testosterone levels (testosterone 48.7 ng/dL) and advanced bone age (12.3 years). Serum levels of LH and FSH were high (LH 3.5 mIU/ mL and FSH 8.3 mIU/mL, respectively). Pituitary MRI was normal.
LHRH analogue therapy was started at 9.3 years and discontinued at 12.5 years, when the patient had bone age of 13.8 years. After discontinuing LHRH therapy, the patient demonstrated spontaneous pubertal progression with pubertal gonadotropin and testosterone.
At 13.5 years, Ph 3, testis 6 mL. Serum levels of LH, FSH and testosterone increased (LH 8.2 mIU/mL, FSH 20.4 mIU/mL and testosterone 391.8 ng/dL, respectively).
| Longitudinal studies of reproductive hormones
Prader-Willi syndrome males in early childhood (1.9 ± 1.1 years)
showed normal LH (0.3 ± 0.4 mIU/mL), FSH (1.9 ± 1.3 mIU/mL), and testosterone (7.6 ± 5.5 ng/dL) levels compared with the ref-
erence range (Table 1) ; hCG stimulation tests were performed at 1.2 ± 0.5 years in 11 cases, and 10 (90.9%) showed normal reactions. The testosterone peak level was 345.1 ± 300.9 ng/dL (59.4-1000 ng/dL). Serum levels of LH and FSH were within the normal range prior to the onset of puberty (8.3 ± 2.4 years). After the onset of puberty (11.0 ± 1.9 years), LH and FSH levels significantly increased (2.0 ± 2.2 mIU/mL and 7.6 ± 6.6 mIU/mL, respectively), but they were within the normal range ( Figure 1 ). Two years after the onset of puberty (13.0 ± 2.0 years) and in adults, the FSH level was persistently highly elevated compared with the reference range (19.5 ± 8.6 mIU/mL), but the LH level remained normal (4.0 ± 1.2 mIU/mL). Testosterone levels significantly increased after the onset of puberty, but they were low (247.7 ± 123.4 ng/dL) in adults; two patients (11.7%) continued to have low LH, FSH and testosterone levels until the age of 15 years.
| Testicular histology in cryptorchidism with PWS
Of nine testes in nine patients available for pathological assessments ( Nistal score of III. In category III, a total of three testes showed SCOS (Figure 2) . Six (66.6%) showed spermatogonia. The mean age at testicular biopsy was 2.2 ± 1.6 years.
The relationship between the age at surgery and testicular histology was examined to clarify why favourable histology (Nistal I) tended to occur in younger patients (mean age 1.4 years), while unfa- 
| D ISCUSS I ON
In this study, the longitudinal data related to the clinical signs of pubertal development and reproductive hormones were reported in PWS males from infancy to adulthood. Furthermore, testicular histology in childhood was assessed, and the association between testicular histology and gonadal function was evaluated in adolescents and adult males with PWS.
It was found that the LH level was normal compared with a refer- in prepubertal males with PWS. After the onset of puberty, most PWS males showed decreasing inhibin B levels to below the 5th percentile. 6, 23 Elevated FSH levels were associated with decreasing inhibin B levels. In the present study, most PWS children showed normal reactions to the hCG stimulation test, which indicated that the function of Leydig cells was normal before puberty onset. It has been reported that normal increases of LH, FSH and testosterone levels occur in PWS infants within a few months after birth, so-called mini-puberty, 23, 24 whereas patients with isolated hypogonadotropic hypogonadism (IHH) show no testosterone rise during infancy. 25 In the present study, approximately 10% of PWS males had low LH, FSH and testosterone levels after the onset of puberty.
These results are similar to the finding of Radicioni et al, 7 who found hypogonadotropic hypogonadism in 5 of 24 PWS males older than 13.5 years.
Similar to other reports, the present results confirmed that most PWS males start puberty spontaneously but do not reach Tanner stage 4-5. 7, 22 Although cryptorchidism is common in PWS males, testicular volume was below the 5th percentile compared with agematched normal testes during early in childhood. The testes grew less than in normal males after puberty (>14 mL in healthy adults).
In this study, penile length was not confirmed, but there have been conflicting reports about penile length. Micropenis was considered to be a common feature of PWS males. 26 In contrast, Hirsch et al 22 reported normal penile length during infancy and early in childhood, but most adults had penile length below the lower limit of normal.
Precocious puberty in PWS males is rare, but several cases have been reported in the literature. 24, [27] [28] [29] The mechanism of precocious puberty in PWS is uncertain. It has been reported that the mutation in MKRN3 gene, an imprinted gene located in the PWS critical region (chromosome 15q11-q13) is associate with familial central precocious puberty. 30 Ischaemic damage of the brain has been implicated in precocious puberty in PWS. three had TFI 30%-60%, seven had TFI <30% and three had SCOS.
They demonstrated that younger age and greater testosterone increases or higher inhibin B levels during hCG stimulation were correlated with favourable TFI. 10 In the present study, younger age at surgery tended to be associated with favourable testicular histology, but a lower position of the testis did not tend to be associated with a favourable histology. Further, a normal reaction was observed on the hCG stimulation test, even in cases with severely decreased numbers or total absence of spermatogonia.
No previous reports have evaluated the association between testicular histology in childhood and long-term gonadal function in PWS males. In the present study, regardless of the testicular histology in childhood, four of five cases who reached puberty showed FSH levels that were persistently elevated after puberty, which indicated that hypogonadism in PWS arises after puberty as a consequence of primary testicular dysfunction. On the other hand, there has been one report of the testicular tissue of PWS in adulthood, and it showed Sertoli cell hyperplasia with the formation of Sertoli cell nodules, markedly vacuolized Leydig cells, and atrophic tubules with peritubular hyalinization. 11 In childhood, the testicular histology of PWS males seems to be different from that of KS males in the heterogeneity that is seen in PWS, with normal testicular histology to SCOS. It has been reported that C15orf2, of which biallelic transcription is observed entirely in the testis, has an important role in spermatogenesis. 32 It is suspected that genes located in the PWS critical region 15q11-13 might have a role directly or indirectly in this process of early gonadal failure. 32 In PWS boys, the disorder of testicular tissue may progress prenatally, unlike KS. Cryptorchidism was reported in only 14% of KS cases, and scrotal hypoplasia was not seen. 31 This suggests that the foetal gonadotropin and androgen environment differs between PWS and KS. The difference in the foetal hormonal environment between PWS and KS might be correlated with the observed differences in testicular histological findings.
Some limitations of the present study must be acknowledged.
This investigation was retrospective and limited to follow-up from infancy to adulthood, and about half of the patients did not reach puberty. Unfortunately, histology was available only in a limited number of cases with cryptorchidism, and histology data were limited to childhood. Further studies of the associations between testicular histology and molecular genetic factors and endocrine function in PWS are therefore necessary.
In conclusion, testicular histology of PWS men in childhood varies from normal to SCOS. Regardless of the testicular histology in childhood, hypogonadism in PWS adults arises as a consequence of primary testicular dysfunction with highly elevated FSH and insufficient testosterone levels.
ACK N OWLED G EM ENTS
The authors are very grateful to Dr. K Shimada and Dr. K Yazawa (Departments of Urology, Osaka Women's and Children's Hospital)
for providing surgical data.
CO N FLI C T O F I NTE R E S T
Nothing to declare. 
AUTH O R S CO NTR I B UTI O N
E TH I C S S TATEM ENT
Not required.
DATA ACCE SS I B I LIT Y
All data are included within the manuscript.
O RCI D
Satoko Matsuyama
http://orcid.org/0000-0002-2460-0313
Futoshi Matsui http://orcid.org/0000-0002-7102-6115
